# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-09T13:40:22.503735
**Route:** OpenRouter + LaTeX
**Paper Hash:** 1f4fccc99483bd39
**Tokens:** 18035 in / 2253 out
**Response SHA256:** b0178a133a1920a3

---

I checked the paper for fatal errors only, focusing on data-design alignment, regression sanity, completeness, and internal consistency.

Findings:

- **Data-design alignment:** No fatal misalignment found.
  - Treatment timing (June 2020–January 2021 ON; February 2021 onward OFF) is covered by the stated sample period (2018–2023).
  - There are both pre-treatment and post-treatment observations.
  - The treatment timing is broadly consistent across the abstract, data section, empirical strategy, and results.

- **Regression sanity:** No fatal regression-output problems found in the reported tables.
  - No impossible values (negative SEs, R² outside [0,1], NA/NaN/Inf in regression results).
  - Coefficients and standard errors are in plausible ranges for log-price outcomes.
  - No columns show obviously exploded estimates suggestive of fatal collinearity artifacts.

- **Completeness:** No fatal incompleteness found.
  - Regression tables report **N**.
  - Standard errors are reported.
  - Referenced tables/figures appear to exist in the LaTeX source.
  - Analyses described in the methods are represented in the results/appendix.

- **Internal consistency:** No fatal contradiction found.
  - Reported sample counts are internally coherent: summary-statistic counts sum to 6,866, while regression N = 6,862 is explicitly explained by dropping four singleton FE observations.
  - Main coefficients cited in text match Table \ref{tab:main_results}.
  - Robustness and placebo tables are numerically consistent with the narrative.

I did not find any issue that would make the empirical design impossible, the regression output obviously broken, or the manuscript plainly incomplete.

ADVISOR VERDICT: PASS